HYPHEN BioMed - Product Owner Profile
Explore comprehensive product owner profile for HYPHEN BioMed through Pure Global AI's free Singapore medical device database. This company owns 6 medical devices registered with HSA across 2 device classes. Their registration history spans from Jun 05, 2020 to Nov 15, 2024.
This page provides detailed insights including recent registrations, device class distribution (CLASS B IVD: 3, CLASS C IVD: 3), and complete regulatory information from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry.
Free Owner Profile
Powered by Pure Global AI
6 Devices
2 Device Classes
HYPHEN BioMed
Product Owner
6
Total Devices
2
Device Classes
2020
Earliest
2024
Latest
Recent Registrations
Latest 10 HSA device registrations
HYPHEN BIOPHEN DiXal
DE0510047
CLASS C IVD
Nov 15, 2024
HYPHEN Revohem Arachidonic acid
DE0504660
CLASS C IVD
Jul 01, 2020
HYPHEN Revohem ADP
DE0504614
CLASS C IVD
Jun 19, 2020
HYPHEN Revohem Epinephrine
DE0504562
CLASS B IVD
Jun 05, 2020
HYPHEN Revohem Ristocetin
DE0504563
CLASS B IVD
Jun 05, 2020
HYPHEN Revohem Collagen
DE0504564
CLASS B IVD
Jun 05, 2020
Device Class Distribution
Devices by class
CLASS B IVD
3
50.0% of total
CLASS C IVD
3
50.0% of total

